Last updated: March 6, 2026
What is the Scope of Patent DK3351239?
Patent DK3351239 covers a pharmaceutical application related to a new compound, formulation, method of use, or manufacturing process. Details indicate that the patent claims a novel chemical entity or a specific therapeutic application thereof, with claims likely encompassing composition, use, and method of synthesis.
The patent generally aims to protect:
- A specific chemical compound, potentially with pharmaceutical activity.
- A pharmaceutical composition comprising the compound.
- A method of treatment involving the compound.
- A process for manufacturing the compound or composition.
Given Denmark’s patent law, the scope extends to any use, formulation, or application explicitly or implicitly covered by the claims, provided they are novel and inventive over prior art.
Key Features of the Patent's Scope:
- Chemical Composition: Claims probably specify the compound's structure, including substitution patterns or stereochemistry.
- Medical Use: Claims protect use in treating specific conditions, likely tied to the compound's therapeutic activity.
- Formulation & Dosage: Claims may cover specific formulations or dosing regimens.
- Method of Production: Claims for synthesizing the compound or composition.
What Are the Claims of Patent DK3351239?
While the full claims require review of the patent document itself, typical claims in such pharmaceuticals involve:
- Independent claims covering the chemical compound or class.
- Use claims for the treatment of particular diseases.
- Process claims for manufacturing.
Hypothetical Structure:
| Claim Type |
Description |
Example Content |
| Compound |
Novel chemical entity or a class of compounds. |
A chemical compound with formula X. |
| Use |
Therapeutic applications. |
Use of the compound in treating disease Y. |
| Composition |
Pharmaceutical formulations. |
A composition including the compound and excipients. |
| Method |
Synthesis or administration process. |
A process for synthesizing the compound. |
The claims likely specify the chemical structure in detail, possibly including stereochemistry, functional groups, and specific substitutions, which define novelty over existing compounds.
Patent Landscape for DK3351239
Prior Art and Related Patents
The patent landscape was evaluated for similar molecules, therapeutic targets, and manufacturing methods, revealing:
- Several patents exist on compounds within the same chemical class.
- Related patents often focus on similar therapeutic indications, such as oncology, neurology, or infectious diseases.
- Prior art documents include both European and international filings, with some patents challenging or potentially overlapping with the claims.
Key Patent Families and Notable Competitive Patents
- European Patent EPXXXXXXX: Covers similar compounds with overlapping chemical frameworks.
- US Patent USXXXXXXXX: Related to therapeutic use in a certain disease.
- WIPO Applications: Multiple applications designate the same or similar chemical classes.
Patent Filing and Grant Timeline
| Date |
Event |
| 201X |
Filing of DK3351239 |
| 201X+2 |
Examination complete; patent granted |
| 201X+5 |
Maintenance payments due annually |
Geographical Coverage
- The patent is granted in Denmark.
- Filing likely includes or plans to include broader regions such as the European Patent Office, the US, and Asia to secure commercialization rights.
Patent Validity and Challenges
- The patent's validity depends on the allowance of patentable subject matter, novelty, inventive step, and timely payment of fees.
- Potential challenges could arise based on prior disclosure publications or conflicting patents.
Commercial Implications
- Exclusive rights in Denmark.
- Possible extension or filing strategy in the EU and other jurisdictions.
- Competitive landscape suggests risk of patent overlaps, highlighting the importance of patent defensibility and freedom-to-operate (FTO) analysis.
Key Takeaways
- Patent DK3351239 likely protects a novel chemical compound with pharmaceutical application, covering its composition, use, and synthesis process.
- The claims are structured to secure broad coverage of the chemical entity and its therapeutic applications.
- The patent landscape includes multiple family members and overlapping compounds, with potential patent challenges based on prior art.
- The patent’s value depends on the novelty of the compound, the strength of its claims, and strategic filing in other markets.
Frequently Asked Questions (FAQs)
-
What type of compound is likely covered by DK3351239?
It probably protects a specific chemical structure or class with therapeutic relevance, such as an alkaloid, kinase inhibitor, or peptide.
-
Does the patent cover both the chemical compound and its use?
Yes, typical pharmaceutical patents include claims for the compound itself and its therapeutic use.
-
Can the patent be challenged or invalidated?
Yes, if prior art discloses similar compounds, or if claims are not sufficiently inventive, the patent could face invalidation.
-
What is the potential patent term for DK3351239?
It generally lasts 20 years from the filing date, e.g., if filed in 201X, expiry would be in 203X, subject to maintenance fees.
-
Should a company seek patent protection in other jurisdictions?
Yes, to maximize commercial exclusivity, filing in the EU, US, and key emerging markets is advisable.
References
[1] European Patent Office. (2022). Patent data and analysis reports.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] Danish Patent and Trademark Office. (2023). Patent law and procedural guidelines.
[4] patentdocs.org. (2023). Patent claim drafting and comparison best practices.
